Skip to main navigation Skip to search Skip to main content

Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study

Research output: Contribution to journalArticleAcademicpeer-review

25 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)30-37
Number of pages8
JournalEuroIntervention
Volume12
Issue number1
DOIs
Publication statusPublished - 2016

Research programs

  • EMC COEUR-09

Cite this